XML 21 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue:      
Revenue $ 233,662 $ 2,785 $ 6,689
Costs and expenses:      
Cost of revenue 14,131 265 790
Research and development:      
Noncash compensation 13,010 13,224 24,047
Other research and development 63,182 112,128 198,532
Total research and development 76,192 125,352 222,579
Selling, general and administrative:      
Noncash compensation 24,923 5,961 37,227
Other selling, general and administrative 97,783 64,046 90,863
Total selling, general and administrative 122,706 70,007 128,090
Total costs and expenses 213,029 195,624 351,459
Operating income (loss) 20,633 (192,839) (344,770)
Other expense (income):      
Interest expense 12,615 10,191 5,638
Other income (5,044) (4,695) (2,307)
Total other expense (income), net 7,571 5,496 3,331
Net income (loss) before taxes 13,062 (198,335) (348,101)
Income taxes 390 0 0
Net income (loss) $ 12,672 $ (198,335) $ (348,101)
Net income (loss) per common share:      
Basic (in dollars per share) $ 0.09 $ (1.46) $ (2.63)
Diluted (in dollars per share) $ 0.09 $ (1.46) $ (2.63)
Weighted-average shares outstanding:      
Basic (in shares) 141,955,112 135,411,258 132,222,753
Diluted (in shares) 148,508,465 135,411,258 132,222,753
Product [Member]      
Revenue:      
Revenue $ 92,005 $ 2,633 $ 6,537
License [Member]      
Revenue:      
Revenue $ 141,657 $ 152 $ 152